| Authors: |
Wagenius G; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; Theme Cancer, Medical Unit Head and Neck, Lung, and Skin Tumors, Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden. gunnar.wagenius@regionstockholm.se., Vikström A; Department of Respiratory Medicine, Linköping University Hospital, Linköping, Sweden., Berglund A; Epistat AB, Uppsala, Sweden., Salomonsson S; MSD, Value and Implementation Outcomes Research, Stockholm, Sweden., Bencina G; MSD, Value and Implementation Outcomes Research, Madrid, Spain., Hu X; Merck & Co., Inc., Value and Implementation Outcomes Research, Rahway, New Jersey, USA., Chirovsky D; Merck & Co., Inc., Value and Implementation Outcomes Research, Rahway, New Jersey, USA., Brunnström H; Lund University, Department of Clinical Sciences Lund, Division of Pathology, Lund, Sweden; Department of Genetics, Pathology, and Molecular Diagnostics, Skåne University Hospital, Lund, Sweden. |
